SCHEDULE: Goldman Sachs Files Schedule 13G for Acadia Healthcare

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 1.6% of Acadia Healthcare Company, Inc.'s common stock as of March 31, 2026.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership reporting for Acadia Healthcare Company, Inc.
• The reporting persons are The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC.
• As of March 31, 2026, The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC collectively beneficially own 1,464,125.72 shares of Acadia Healthcare Company, Inc. common stock.
• This represents 1.6% of the class of securities.
• Goldman Sachs & Co. LLC is identified as a broker-dealer and investment adviser.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
• A Power of Attorney is in effect until July 16, 2026, authorizing specific individuals to execute and deliver required filings on behalf of The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing. It is a routine disclosure of beneficial ownership by a financial institution and does not contain operational or strategic updates about Acadia Healthcare itself.

Positives

• Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, is involved in the filing, suggesting a structured and compliant approach to ownership reporting.
• The filing explicitly states that the securities were acquired and are held in the ordinary course of business, not for the purpose of influencing control, which is a standard certification for such filings.

Risks

• While not explicitly stated as a risk in this filing, any significant change in beneficial ownership by a major financial institution like Goldman Sachs could be interpreted by the market as a signal, though the filing itself is routine for such entities.
• The Power of Attorney has an expiration date of July 16, 2026, and its cessation could require new authorizations for future filings.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a routine disclosure of beneficial ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for institutional investors and financial entities like Goldman Sachs when their beneficial ownership of a public company's stock crosses certain thresholds. This filing indicates Goldman Sachs's ongoing role as a significant holder or facilitator of shares in the healthcare services sector, represented by Acadia Healthcare.

Stakeholder Impact

• Shareholders: This filing provides transparency regarding institutional ownership, which can be a factor in market perception, but does not directly alter share value or rights.
• Creditors: No direct impact is indicated.
• Employees: No direct impact is indicated.
• Suppliers/Customers: No direct impact is indicated.

Next Steps

• The Power of Attorney for executing filings is valid until July 16, 2026, after which a new authorization may be required.
• Future amendments to Schedule 13G will be filed if there are further changes in beneficial ownership exceeding reporting thresholds.

Key Dates

Keywords

Schedule 13G, Acadia Healthcare, Goldman Sachs, Beneficial Ownership, SEC Filing, Common Stock, Broker-Dealer, Investment Adviser, Securities Exchange Act